Your search for non small cell lung cancer returned 32 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Brian Park, PharmD remove
Last 2 years remove

Your search for non small cell lung cancer returned 32 results

Sort Results:

Relevant Recent
News

Rybrevant Approved for NSCLC With EGFR Exon 20 Insertion Mutations

The approval was based on data from the phase 1 CHRYSALIS trial that evaluated Rybrevant in 81 patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations whose disease had progressed on or after platinum-based chemotherapy.
News

Lumakras Gets Accelerated Approval for KRAS G12C-Mutated NSCLC

The Food and Drug Administration (FDA) has granted accelerated approval to Lumakras (sotorasib) for the treatment of adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least 1 prior systemic therapy. Sotorasib, an inhibitor of the RAS GTPase family, works by…